Lawrence Otto Klein Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Lawrence Otto Klein.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Lawrence Otto Klein. Lawrence Otto Klein is CBO & COO in CRISPR Therapeutics AG ($CRSP) and Chief Business Officer in CRISPR Therapeutics AG ($CRSP) and Director in Dyne Therapeutics, Inc. ($DYN).

Latest Insider Trading Transactions of Lawrence Otto Klein

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CRSP, DYN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	44.67	12,000	536,040	43,000
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	40.87	20,000	817,400	25,000
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	29.87	10,000	298,700	10,000
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	51.49	22,000	1,132,780	38,000
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	17.66	12,000	211,920	3,000
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	14.43	12,000	173,160	2,666
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	126.97	12,000	1,523,640	1,050	13.1 K to 1.1 K (-91.95 %)
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	128.20	88,000	11,281,600	13,050	101.1 K to 13.1 K (-87.09 %)
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	17.66	12,000	211,920	101,050	89.1 K to 101.1 K (+13.48 %)
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	14.43	12,000	173,160	89,050	77.1 K to 89.1 K (+15.57 %)
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	40.87	20,000	817,400	77,050	57.1 K to 77.1 K (+35.06 %)
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	29.87	10,000	298,700	57,050	47.1 K to 57.1 K (+21.25 %)
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	51.49	22,000	1,132,780	47,050	25.1 K to 47.1 K (+87.82 %)
Mar 25 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	44.67	12,000	536,040	25,050	13.1 K to 25.1 K (+91.95 %)
Mar 12 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	A	0.00	12,000	0	12,000
Mar 12 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	A	133.88	33,334	4,462,756	33,334
Mar 12 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Payment of Exercise	F	124.15	2,141	265,805	13,050	15.2 K to 13.1 K (-14.09 %)
Mar 12 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	0.00	4,583	0	15,191	10.6 K to 15.2 K (+43.20 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	14.43	16,334	235,700	14,666
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	12.57	8,666	108,932	0
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	219.99	2	440	20,000	20 K to 20 K (-0.01 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	218.54	701	153,197	20,002	20.7 K to 20 K (-3.39 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	217.42	9,997	2,173,548	20,703	30.7 K to 20.7 K (-32.56 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	216.39	1,500	324,585	30,700	32.2 K to 30.7 K (-4.66 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	214.60	700	150,220	32,200	32.9 K to 32.2 K (-2.13 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	213.64	2,800	598,192	32,900	35.7 K to 32.9 K (-7.84 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	212.20	634	134,535	35,700	36.3 K to 35.7 K (-1.74 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	14.43	16,344	235,844	36,334	20 K to 36.3 K (+81.76 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	217.45	200	43,490	20,000	20.2 K to 20 K (-0.99 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	216.24	400	86,496	20,200	20.6 K to 20.2 K (-1.94 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	214.46	1,400	300,244	20,600	22 K to 20.6 K (-6.36 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	213.71	1,200	256,452	22,000	23.2 K to 22 K (-5.17 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	212.54	2,555	543,040	23,200	25.8 K to 23.2 K (-9.92 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	211.44	2,911	615,502	25,755	28.7 K to 25.8 K (-10.15 %)
Jan 20 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	12.57	8,666	108,932	28,666	20 K to 28.7 K (+43.33 %)
Jan 04 2021	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Payment of Exercise	F	153.11	9,392	1,438,009	10,608	20 K to 10.6 K (-46.96 %)
Oct 06 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	A	86.75	16,666	1,445,776	16,666
Sep 23 2020	DYN	Dyne Therapeutics, ...	Klein Lawrence Otto	Director	Option Exercise	C	0.00	35,574	0	0
Sep 23 2020	DYN	Dyne Therapeutics, ...	Klein Lawrence Otto	Director	Option Exercise	P	0.00	35,574	0	35,574
Sep 23 2020	DYN	Dyne Therapeutics, ...	Klein Lawrence Otto	Director	Option Exercise	A	5.54	14,444	80,020	14,444
Sep 23 2020	DYN	Dyne Therapeutics, ...	Klein Lawrence Otto	Director	Option Exercise	A	5.54	11,156	61,804	11,156
Sep 23 2020	DYN	Dyne Therapeutics, ...	Klein Lawrence Otto	Director	Buy	C	0.00	10,725	0	10,725	0 to 10.7 K
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	12.57	4,912	61,744	8,666
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	12.57	26,422	332,125	13,578
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	5.86	38,666	226,583	0
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	75.18	4,912	369,272	20,000	24.9 K to 20 K (-19.72 %)
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	12.57	4,912	61,744	24,912	20 K to 24.9 K (+24.56 %)
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	76.26	2,913	222,138	20,000	22.9 K to 20 K (-12.71 %)
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	75.32	12,175	917,054	22,913	35.1 K to 22.9 K (-34.70 %)
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	76.50	800	61,201	35,088	35.9 K to 35.1 K (-2.23 %)
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	75.94	3,934	298,736	35,888	39.8 K to 35.9 K (-9.88 %)
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	74.90	6,600	494,323	39,822	46.4 K to 39.8 K (-14.22 %)
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	12.57	26,422	332,125	46,422	20 K to 46.4 K (+132.11 %)
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	76.50	22,700	1,736,575	20,000	42.7 K to 20 K (-53.16 %)
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	75.93	15,966	1,212,265	42,700	58.7 K to 42.7 K (-27.22 %)
Jun 26 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	5.86	38,666	226,583	58,666	20 K to 58.7 K (+193.33 %)
May 13 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Option Exercise	M	5.86	25,000	146,500	38,666
May 13 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	61.07	682	41,650	20,000	20.7 K to 20 K (-3.30 %)
May 13 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Sell	S	60.38	24,318	1,468,321	20,682	45 K to 20.7 K (-54.04 %)
May 13 2020	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	CBO & COO	Buy	M	5.86	25,000	146,500	45,000	20 K to 45 K (+125.00 %)
Dec 05 2019	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	Chief Business Offi ...	Option Exercise	A	0.00	40,000	0	40,000
Sep 12 2019	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	Chief Business Offi ...	Option Exercise	A	0.00	10,000	0	30,000
Jul 12 2019	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	Chief Business Offi ...	Option Exercise	M	5.86	8,421	49,347	63,666
Jul 12 2019	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	Chief Business Offi ...	Option Exercise	M	5.86	11,579	67,853	72,087
Jul 12 2019	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	Chief Business Offi ...	Sell	S	50.01	8,421	421,171	20,000	28.4 K to 20 K (-29.63 %)
Jul 12 2019	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	Chief Business Offi ...	Buy	M	5.86	8,421	49,347	28,421	20 K to 28.4 K (+42.11 %)
Jul 12 2019	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	Chief Business Offi ...	Sell	S	50.02	11,579	579,182	20,000	31.6 K to 20 K (-36.67 %)
Jul 12 2019	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	Chief Business Offi ...	Buy	M	5.86	11,579	67,853	31,579	20 K to 31.6 K (+57.90 %)
Mar 07 2019	CRSP	CRISPR Therapeutic ...	Klein Lawrence Otto	Chief Business Offi ...	Option Exercise	A	40.87	45,000	1,839,150	45,000

Page: 1